Migraine Therapy
Mimicking Environmental Enrichment for Migraine Therapy
Yuan Zhang, Ph.D.
Seurat Therapeutics
PAP-Q3-19-CL-026Oct 28, 2019
Chronic Migraine
Migraine Drugs Market Size Worth $7.8 Billion by 2025 | CAGR: 18.0%: Grand View Research, Inc.
Grand View Research
PR-M12-18-NI-023Dec 07, 2018
Market Prediction
Migraine Drugs Market Rising at Steady 3.5% During 2017 - 2025; Abortive Treatment Generates Maximum Revenue - TMR
Transparency Market Research
PR-M11-18-NI-011Nov 05, 2018
FDA Approval
New Treatment Option for Migraine Suffers
Emilie Branch
Pharma's Almanac
PAO-M10-18-NI-005Oct 04, 2018
Prevention Trial
Chronic Migraine Prevention Trial Shows Positive Results for Cefaly® PREVENT Medical Device
Cefaly Technology
PR-M06-18-NI-020Jun 07, 2018